Koninklijke Philipsの空売り状況は、投資家がKoninklijke Philipsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Koninklijke Philips (NYSE:PHG) 株価情報, 空売り情報

Koninklijke Philips

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips NV

Phil-Good Products Inc

BiomX Inc

BiomX Inc Warrants (13/12/2023)

PETS AT HOME GRP UNSP/ADR by Pets at Home Group PLC

Pets at Home Group PLC

PHARMING GROUP NV ORD by Pharming Group NV

Pharming Group

<a href="https://www.philips.com/a-w/about/news/archive/standard/news/articles/2025/philips-collaborates-with-nvidia-to-improve-patient-care-in-mr-with-latest-ai-advances#:~:text=Philips%20collaborates%20with%20NVIDIA%20to,MR%20with%20latest%20AI%20advances&amp;text=From%20cutting%20scan%20times%2C%20to,for%20their%20patients%20%5B1%5D.">https://www.philips.com/a-w/about/news/archive/standard/news/articles/2025/philips-collaborates-with-nvidia-to-improve-patient-care-in-mr-with-latest-ai-advances#:~:text=Philips%20collaborates%20with%20NVIDIA%20to,MR%20with%20latest%20AI%20advances&amp;text=From%20cutting%20scan%20times%2C%20to,for%20their%20patients%20%5B1%5D.</a>
&nbsp;
From cutting scan times, to speeding workflow and improving image quality, Philips is already empowering healthcare providers with AI-powered solutions to deliver faster, more accurate diagnoses for their patients [1]. Today at a major industry gathering <a href="https://www.usa.philips.com/healthcare/event/upcoming/ismrm-2025">ISMRM</a>, the company announced a new breakthrough collaboration with NVIDIA to harness cutting-edge advances in AI for MR imaging.
 &nbsp;

News

NVDA

Reported Earlier: 'Philips Collaborates With NVIDIA To Improve Patient Care In MR With Latest AI Advances' - Phillips

Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported first-quarter 2025 adjusted earnings per share of 26 cents (or 0.25 euros), beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of 20 cents</a>.
The Dutch healthcare technology group reported quarterly sales of $4.31 billion (4.09 billion euros), beating the consensus of $4.10 billion.
Comparable <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45213459/philips-delivers-on-q1-results-with-ongoing-order-intake-growth" rel="noreferrer noopener">sales decreased</a> by 2%, including a double-digit decline in China.
<ul>
<li>Diagnosis &amp; Treatment comparable sales decreased by 4%, due to a double-digit decline in China and on the back of a high comparison base in prior years. Adjusted EBITA margin improved, driven by productivity measures, mix effects, and innovation, partly offset by lower fixed cost absorption due to lower sales.</li>
<li>Connected Care comparable sales were broadly flat across businesses, and the Adjusted EBITA margin was 3.5%, mainly due to an unfavorable mix and cost phasing, partly offset by productivity measures and innovation.</li>
<li>Personal Health comparable sales increased 1%. A double-digit decline in China largely offset high-single-digit growth. The adjusted EBITA margin remained in line with last year&#8217;s.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45147390/ge-healthcares-strong-q1-took-back-seat-to-tariffs-analyst-sees-2026-tariff-impact-less-than-2025" rel="noreferrer noopener">GE HealthCare&#8217;s Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025</a>
&#8220;Our order intake growth continued with strong momentum, particularly in the US, coupled with positive growth in personal health, providing an encouraging start to the year,&#8221; said Roy Jakobs, CEO of Royal Philips.
&#8220;In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control. We are improving our supply chain agility, taking decisive cost actions to mitigate financial impact where possible, and ensuring we can continue to serve our customers and consumers,&#8221; Jakobs added.
Adjusted EBITA margin decreased 80 basis points to 8.6%, mainly due to the decline in sales, partly offset by higher gross margins from innovations and productivity measures.
Income from operations increased to 154 million. Free cash flow was an outflow of 1.09 billion, mainly due to the 1.025 billion payment relating to the Philips Respironics recall-related medical monitoring and personal injury settlements in the U.S.
Guidance:&nbsp;In an uncertain macro environment, Philips&#8217; outlook for the full year 2025 is updated to include the assumed impact of currently announced tariffs, including current bilateral US-China and rest of world tariffs, and the resumption of the paused U.S. tariffs on July 9. It excludes the potential wider economic impact.
2025 comparable sales growth of <a target="_blank" href="https://www.benzinga.com/general/health-care/25/02/43817640/philips-stock-falls-as-china-weakness-drags-q4-earnings-2025-outlook" rel="noreferrer noopener">1%—3% remains unchanged</a>.
Adjusted EBITA margin range to be 10.8%-11.3% (compared to 11.8%-12.3% previously), including an estimated net tariff impact of 250-300 million euros after substantial tariff mitigations.
The company anticipates that 2025 performance will be skewed toward the latter part of the year, with Q2 showing modest improvement from Q1.
Philips is on track to deliver savings of 800 million euros in 2025.
Price Action: PHG stock is down 4.76% to $24.42&nbsp;at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45210400/ahead-of-uber-earnings-analyst-raises-forecast" target="_blank" rel="noreferrer noopener">Ahead Of Uber Earnings, Analyst Raises Forecast</a></li>
</ul>
Photo by Mats Wiklund via Shutterstock

Earnings

Large Cap

Guidance

Health Care

Movers

Trading Ideas

General

Lower Demand In China Disrupts Philips Q1 Sales, Cuts 2025 Profitability Target On Potential Tariff Impact

WIIM

Koninklijke Philips shares are trading lower after the company reported Q1 financial results and trimmed its adjusted EBITA margin. Also, the company reported a year-over-year decrease in comparable sales.

ACLS

AHCO

ALAB

ALGS

ALGT

AMTM

ANDE

ANET

ANGI

ARDT

ARIS

ARMK

ARQT

ARRY

ATKR

ATOM

ATRO

AUDC

AVNS

AVNT

AVNW

AZEK

BALL

BBNX

BCAB

BLDP

BRLT

BWIN

BWMN

CCCS

CCLD

CDRE

CELH

CGAU

CGBD

CHMI

CHRD

CIFR

CIGI

CLDT

CLOV

COTY

CPAY

CPIX

CPNG

CRCT

CRIS

CRMD

CRSR

CRUS

CURI

CVGI

CXDO

CYTK

DASH

DAWN

DDOG

DOCN

DRCT

DRVN

DVAX

ENLT

EOSE

Embraer-Empresa Brasileira De Aeronautica

ESPR

EVGO

Earnings Scheduled For May 6, 2025

Outlook&nbsp;
In an uncertain macro environment, Philips' outlook for full year 2025 is updated to include the assumed impact of currently announced tariffs. This includes current bilateral US-China and rest of world tariffs, the resumption of the paused US tariffs on July 9 and excludes potential wider economic impact.
&nbsp;• Philips' outlook for comparable sales growth remains unchanged at 1%-3%
&nbsp;• Adjusted EBITA margin range to be 10.8%-11.3%, including an estimated net tariff impact of EUR 250-300 million after substantial tariff mitigations, a 100 bps reduction versus previous outlook, based on the above-referenced assumptions
&nbsp;• As a result, free cash flow to be slightly positive for the full year, after the payout of EUR 1,025 million Philips Respironics recall-related medical monitoring and personal injury settlements in the US
&nbsp;• The company continues to anticipate 2025 performance will be skewed toward the latter part of the year, with Q2 showing modest improvement from Q1

Koninklijke Philips Holds 2025 Sales Growth Outlook At 1–3%; Trims Adjusted EBITA Margin To 10.8%-11.3%, Down 100 Bps From Prior On €250–300M Tariff Hit

Koninklijke Philips Comparable Sales Fell 2% YoY, With China Down Double Digits; Personal Health Rose 1%, But Diagnosis & Treatment Dropped 4%

Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.20 by 31 percent. This is a 6.43 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $4.31 billion which beat the analyst consensus estimate of $4.10 billion by 5.16 percent. This is a 4.14 percent decrease over sales of $4.49 billion the same period last year.

Earnings Beats

Koninklijke Philips Q1 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $4.31B Beat $4.10B Estimate

<ul>
<li>Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable faster scanning</li>
<li>Innovations include the latest AI-enabled MR Workspace software to enhance patient throughput, reduce scan times, and improve image quality—leading to more accurate diagnoses, shorter wait times, and reduced backlogs for MRI scans</li>
<li>The latest technology is available across Philips' 1.5T and 3.0T MRI scanners [2], including the latest helium-free 1.5T high-performance BlueSeal wide-bore system [3,4], supporting healthcare providers worldwide</li>
</ul>
Amsterdam, The Netherlands and Vienna, Austria – <a href="https://www.globenewswire.com/Tracker?data=OKgd3pahs2OQXp2t4hkPVLl1U9rIS3SmOHkk6tyZsuLb8QFojiM4ij8_4XeGxDBlZbDWXNKTXLOUJc6NoVc3tMxnGuc5c_t9lXPMIJcbK4M=">Royal Philips</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>, AEX: PHIA))), a global leader in health technology, strengthens its MRI leadership with the launch of SmartSpeed Precise [1], powered by Dual-AI engines. Building on its award-winning [5] <a href="https://www.globenewswire.com/Tracker?data=IMPR-tHgOkNuf-q0b2iHzk38Vi3ewcMDTGkWtvtbSu79bOKVz-WOQlFgsmNaTpM80EZAq0drWfE0tqmDdqVCkJ3zNe9fZ92kSsGod3LGto9pBSSWldZ0RgCy3J-1MIlVY-ZbbYWpb4Oml7EJv-AeX81ohdFHVvdh-CUzt7qUSt7r-TozfvUBurefi0Qkkb_n">Compressed SENSE</a> and <a href="https://www.globenewswire.com/Tracker?data=65mXpke_iCjhmJhIaDGs3Bc-xo0_Ro_8mGPrEx6pWWW0KqYdUYjhy5gfdokUT3bWxu8BRhlnfQJbPMKxAaVi0Fei7rmQZaznwbC1AcH5mtUKCOIIJTX7d1hiETvsmVvzwCiZ5MWoR6zFY9xk-fvIzg==">SmartSpeed</a> technologies, this next-generation solution delivers faster scans with higher image quality. Debuting at the 2025 European Congress of Radiology (<a href="https://www.globenewswire.com/Tracker?data=sZzAy5ub4MbOdn7i70QxsPn8g9m6dkV1-4oqa0AbOWtt_46N-cOdZXW43vjSQFP1MgwvDEpv6SnX_py3NGZGG-uEvl_p50iZ-d5G3lTEDH0=">ECR 2025</a>, Feb. 26-Mar. 2, Vienna, Austria), SmartSpeed Precise significantly improves scan speed and diagnostic image quality, extending AI-driven efficiency across the entire <a href="https://www.globenewswire.com/Tracker?data=y3CI4tgtz6u9YhKgvbCYmA8ErlMo7FbBbbqQjm_tUWJgyke2WspHRo1o7ARm42K9NrpO7bwViqGGXRQoJLFRV4sU3M_i7eY6iF4sPymA-CS-RKr3uCTdhJ3GH1Gxle30eyUtf6qyYNRqSLt5WGe5Dw==">Philips MR portfolio</a>—including existing customer systems. Also showcased will be the latest MR Workspace software release 12 [6], which streamlines workflows and empowering clinicians to deliver faster, more accurate diagnoses. These innovations reflect Philips' commitment to enhancing efficiency, accessibility, and precision in MR imaging. &nbsp;

Biotech

Philips Integrates Advanced AI Into MRI Systems With Dual AI Engines For Faster Scanning, Enhanced Image Quality, And Reduced Wait Times; Innovations Include Helium-Free 1.5T BlueSeal Wide-Bore System

Integrating advanced data analytics into clinical practice to improve patient care

Philips And Mass General Brigham Collaborate To Unify Medical Data With AI For Smarter Clinical Decisions

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies analyst James Heaney upgraded the rating for Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) from Underperform to Hold and raised the price target from $55 to $100. Roku shares closed at $92.41 on Wednesday. <a href="https://www.benzinga.com/quote/ROKU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Matthew Lofting upgraded the rating for BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from Underweight to Neutral. BP shares closed at $34.54 on Wednesday. <a href="https://www.benzinga.com/quote/BP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Christopher Danely upgraded NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) from Neutral to Buy and raised the price target from $210 to $290. NXP Semiconductors shares closed at $245.58 on Wednesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Graham Doyle upgraded Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) from Neutral to Buy. Philips shares closed at $25.05 on Wednesday. <a href="https://www.benzinga.com/quote/PHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Susquehanna analyst Mehdi Hosseini upgraded Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) from Neutral to Positive and raised the price target from $75 to $125. Lam Research shares closed at $87.66 on Wednesday. <a href="https://www.benzinga.com/quote/LRCX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="524" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-1024x524.png" alt="" class="wp-image-791761" style="width:587px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-1024x524.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172.png 1285w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

Upgrades

Price Target

Markets

Analyst Ratings

LRCX

NXPI

ROKU

This BP Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday

UBS analyst Graham Doyle upgrades Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) from Neutral to Buy.

UBS Upgrades Koninklijke Philips to Buy

Dutch healthcare technology group&nbsp;Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) stock is trading lower on Wednesday after the fourth quarter <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43805254/philips-delivers-growth-improved-profitability-and-strong-cash-flow-in-q4-and-2024-continues-solid" rel="noreferrer noopener">earnings missed expectations</a>.
Philips&nbsp;reported fourth-quarter sales of 5.04 billion euros (around $5.26 billion), slightly higher than 5.0 billion euros a year ago, missing the consensus of 5.10 billion euros.
The company reported adjusted EPS of 51 cents, up from 40 cents a year ago, but it missed the consensus of 57 cents.
Comparable order intake increased 2% in the quarter, with strong performance in the North America and Growth geographies, partly offset by a double-digit decline in demand in China.
Group comparable sales increased 1% in the quarter, with a growth of 5% in the rest of the world, largely offset by a double-digit decline in China, where market conditions are expected to remain uncertain. For the full year, comparable order intake and sales increased 1%, up 4% excluding China (within management <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41570381/dutch-health-tech-firm-philips-q3-earnings-miss-expectations-lowers-annual-forecasts-on-weak-demand" rel="noreferrer noopener">guidance of 0.5%-1.5%</a>).
Diagnosis &amp; Treatment&nbsp;and Personal Health&nbsp;comparable sales decreased 1% and 2%, respectively, in the quarter due to a double-digit decline in China.
The fourth-quarter net loss was 334 million euros, compared with a profit of 39 million euros a year ago. The loss mainly reflects a tax charge of 449 million euros against a credit of 132 million euros.
Adjusted EBITA was 679 million euros compared with 653 million euros, while its adjusted EBITA margin was 13.5%.
Guidance: Philips expects 2025 comparable sales growth of 1%—3%, including a mid-to-high single-digit decline in China. The company forecasts that the adjusted EBITA margin will increase 30-80 bps to 11.8%—12.3%.
The Dutch medical technology company anticipates comparable sales growth to be back-end-loaded in the year, with a mid-single-digit decline in Q1 mainly due to lower demand in China and royalties phasing, with correspondingly lower Adjusted EBITA margin.
Philips is raising its productivity savings target for the 2023-2025 period from 2 billion euros to 2.5 billion euros, driven by cost efficiencies and further simplification of its operating model. 800 million euros will be delivered in 2025.
Philips has also provided guidance on free cash flow post-settlements, expecting between 400-600 million euros in 2025.
Price Action: PHG stock is down 11.6% at $25.03 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43794325/jp-morgans-acquisition-of-student-loan-start-up-falls-out-founder-in-court-for-alleged-fraud-ceo-jamie-dimon-calls-it-a-huge-mistake" target="_blank" rel="noreferrer noopener">JPMorgan, Charlie Javice Case Takes Center Stage In Court This Week: Report</a></li>
</ul>
Photo by Mats Wiklund via Shutterstock

Philips Stock Falls As China Weakness Drags Q4 Earnings, 2025 Outlook

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Wednesday.
Shares of Gentherm Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/quote/THRM/news">weak quarterly results.</a>
Gentherm shares dipped 17% to $30.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Supernus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUPN#NASDAQ">SUPN</a>) fell 22% to $31.00 in pre-market trading after the company announced that the Phase 2b study of SPN-820 in adults with treatment-resistant depression did not demonstrate a statistically significant improvement on the primary endpoint of change from baseline in the Montgomery-Åsberg Depression Rating Scale.</li>
<li>InnovAge Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) fell 21.1% to $2.70 in today's pre-market trading. InnovAge recently reported worse-than-expected second-quarter financial results.</li>
<li>Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) declined 17.3% to $6.70 in pre-market trading after the company issued first-quarter revenue guidance below estimates and announced a quarter-over-quarter decline in paying app users.</li>
<li>GCL Global Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCL#NASDAQ">GCL</a>) fell 14.7% to $6.40 in pre-market trading after jumping 153% on Tuesday.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) shares dipped 13.5% to $60.50 in pre-market trading after the company issued first-quarter EPS guidance below estimates.</li>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) declined 11.9% to $24.94 in pre-market trading following weak quarterly results.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) fell 7.7% to $3.60 in pre-market trading.</li>
<li>Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) declined 6.8% to $53.35 in pre-market trading after reporting a 6.8% YoY decline in fourth-quarter GMV and guiding for a similar YoY GMV decline in the first quarter.</li>
<li>Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) fell 5.4% to $115.50 in pre-market trading after the company reported worse-than-expected first-quarter financial results..</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43776863/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter-3">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Pre-Market Outlook

BMBL

ETSY

INNV

SLSR

SUPN

THRM

Gentherm Posts Downbeat Results, Joins Celanese, Bumble And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Koninklijke Philips shares are trading lower following a Q4 adjusted EPS and revenue miss.

U.S. stock futures fell on Wednesday after scaling fresh records in Tuesday&#8217;s session. The futures of all four benchmark indices were trading lower in the premarket.
President Donald Trump, on Tuesday, announced plans to impose a 25% tariff on auto imports, along with tariffs on pharmaceuticals and semiconductor chips.
The auto tariffs are expected to take effect by April 2, based on a report from his cabinet. Tariffs on pharmaceuticals and chips will also start at 25% or higher, with increases over the year. Trump did not specify a start date, allowing manufacturers time to establish U.S. factories to avoid the tariffs.
The 10-year Treasury yield stood at 4.56%, while the two-year yield was at 4.30%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 97.5% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.09%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.43%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were trading below the flatline on Wednesday. SPY fell 0.12% to $610.73, and QQQ dropped 0.093% to $538.87, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Energy, materials, and utilities sectors led the gains in U.S. stocks on Tuesday, propelling the S&amp;P 500 to a<a href="https://www.benzinga.com/news/earnings/25/02/43806227/sp-500-settles-at-record-high-ahead-of-fed-minutes-investor-sentiment-improves-fear-greed-index-moves-to-neutral-zone"> record-high close</a>. Despite the overall positive trend, communication services and consumer discretionary sectors declined on Tuesday. 
The broader market awaited the release of the latest FOMC minutes on Wednesday and monitored other ongoing geopolitical developments.
Last week saw positive momentum across equity markets. The S&amp;P 500 was approximately up 1.5%, the Dow Jones Industrial Average rose 0.6%, and the Nasdaq Composite gained 2.6% last week.
In company news, Fluor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) shares plummeted over 8% after the company reported quarterly earnings and revenue below expectations. On the economic front, the NY Empire State Manufacturing Index exceeded forecasts, rising 18.3 points to +5.7 in February.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.072%</td>
<td>20,041.26</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.24%</td>
<td>6,129.58</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.023%</td>
<td>44,556.34</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.45%</td>
<td>2,290.35</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Ryan Detrick, the chief market strategist at Carson Research, pointed out that the S&amp;P 500 scaled its second all-time high of 2025 on Tuesday.
This was the 1,243rd record high over the 17,176 trading days since 1957 when the gauge increased to having 500 stocks.
Processing this data, Detrick highlighted that the S&amp;P 500 hits a new all-time high about once every three weeks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">And with that we have the 2nd all-time high of 2025 for the S&amp;P 500. Since 1957 (when it become 500 stocks) this is 1,243 ATHs out of 17,176 trading days. In other words, a new ATH happens about once every 3 wks. New highs happen, congrats to the investors who remembered. <a href="https://t.co/D30va9bi5Y">pic.twitter.com/D30va9bi5Y</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1891961462475591906?ref_src=twsrc%5Etfw">February 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also addressed a very important question, "Should you buy when stocks are all-time highs?" in one of his X posts.
Detrick said, "Don&#8217;t be scared of new highs". He substantiated his claims by adding that the index is usually up 71% of the times, a year after scaling an all-time high.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Should you buy when stocks are all-time highs? That&#39;s a popular question we often get. My take is don&#39;t be scared of new highs, as the S&amp;P 500 is up a year later 71% of the time after an ATH and up a median of 8.3%. In other words, about normal returns. <a href="https://t.co/I01bT0Bgwg">pic.twitter.com/I01bT0Bgwg</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1891968184590246018?ref_src=twsrc%5Etfw">February 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about the fresh record, Nathan Peterson, director of derivatives analysis at the <a href="https://www.schwab.com/learn/story/stock-market-update-open">Schwab Center</a> for Financial Research said: &#8220;It seems that stocks can maintain a bullish bias provided the economic data and earnings growth estimates hold up and yields on the 10-year Treasury note remain below the mid-January high of 4.8%." 
According to economist Jeremy Siegel, despite the uncertainties, "The stock market continues to perform well, particularly in the tech sector, even as leadership has broadened beyond last year's AI-driven rally."
Professor of finance at the University of Pennsylvania, Siegel also added that "Tesla took a hit on competition from China's BYD, now the world's largest EV maker. Nvidia was hit after the DeepSeek news, but overall, the tech leaders have remained resilient."
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep On Wednesday:
<ul>
<li>On Wednesday, January&#8217;s housing starts and building permits data will be out by 8:30 a.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s minutes of the Federal Reserve Open Market Committee meeting will be released at 2:00 p.m., ET.</li>
</ul>
<ul>
<li>Fed Vice Chairman Philip Jefferson will speak at 5:00 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) was up 0.58% in the premarket on Wednesday ahead of its earnings, which will be released before the opening bell. Analysts expect it to report quarterly earnings of $1.54 per share on revenue of $2.36 billion.</li>
</ul>
<ul>
<li>Etsy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) advanced 1.24% as Wall Street expects it to report quarterly earnings of 93 cents per share on revenue of $862.82 million. before the opening bell.</li>
</ul>
<ul>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 0.99% ahead of its earnings, which will be released after the closing bell. Analysts expect it to report quarterly earnings of 29 cents per share on revenue of $3.31 billion.</li>
</ul>
<ul>
<li>Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) tumbled 11.69% after reporting downbeat results for its fourth quarter.</li>
</ul>
<ul>
<li>Wix.Com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) jumped 6.68% after reporting earnings of $1.93 per share for the fourth quarter, which beat the analyst consensus. But its sales of $460.455 million missed the consensus of $461.748 million.</li>
</ul>
<ul>
<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) plunged 28.20% after it announced a 1-for-30 reverse share split approved by its board of directors. The consolidation will reduce outstanding common shares from 64,301,183 to approximately 2,143,372 shares.</li>
</ul>
<ul>
<li>Crown Crafts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWS#NASDAQ">CRWS</a>) slumped 34.12%, continuing to fall after its third-quarter sales, profit and EPS declined.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.89% to hover around $72.47 per barrel.
The gold spot index was up by 0.30% to $2,944.20 per ounce. The Dollar Index was up 0.10% at 107.157 level.
Asian markets ended mostly lower on Wednesday. China's CSI 300, and South Korea's Kospi index rose. Whereas, Australia's ASX 200, India's S&amp;P BSE Sensex, Hong Kong's Hang Seng, and Japan's Nikkei 225 index fell. European markets were mixed in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43806703/mark-zuckerbergs-meta-platforms-dips-below-short-term-average-as-it-snaps-20-day-winning-run">Meta Stock Dips Below Short-Term Average As Mark Zuckerberg-Led Tech Giant Snaps 20-Day Winning Streak</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Economics

APTO

CRWS

CVNA

US Stocks Likely To Open Lower Following Fresh Records From Previous Session: Expert Says, 'Don't Be Scared Of New Highs'

ACVA

AMPL

ANSS

APPN

BLCO

BMRN

BORR

CAKE

CCAP

CCSI

CHDN

CLVT

CMTG

CWAN

ENVX

ESRT

EXAS

FOLD

First Trust Advantage Preferred Income Fund

FVRR

GLBE

GRAB

GRMN

HSBC

ICLR

IIPR

IMAX

INSG

IONS

KALU

KPTI

KRYS

KVYO

LAND

LILA

LILAK

LOPE

LUNG

MANU

MATV

MGRC

MTRN

NDSN

NRDS

NYMT

OBDC

PAAS

PERI

PNST

PRAA

Earnings Scheduled For February 19, 2025

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) to report quarterly earnings at $1.54 per share on revenue of $2.36 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Analog Devices shares gained 0.8% to $222.00 in after-hours trading.</li>
<li>Analysts are expecting Etsy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) to post quarterly earnings at 93 cents per share on revenue of $862.82 million. The company will release earnings before the markets open. Etsy shares rose 1.3% to $58.05 in after-hours trading.</li>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported downbeat results for its fourth quarter. However, the healthcare technology company said it sees an increase of 1% to 3% in comparable sales for 2025. Philips shares gained 2.4% to $28.99 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) reported earnings of $1.93 per share for the fourth quarter, which beat the analyst consensus estimate of $1.59 per share. The company reported quarterly sales of $460.455 million which missed the analyst consensus estimate of $461.748 million. Wix shares gained 3% to $234.68 in the after-hours trading session.</li>
<li>Analysts expect Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) to post quarterly earnings at 29 cents per share on revenue of $3.31 billion after the closing bell. Carvana shares gained 0.9% to $286.96 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43776863/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter-3">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>
Photo courtesy: Shutterstock

Analog Devices, Philips And 3 Stocks To Watch Heading Into Wednesday

Philips remains focused on successfully executing its three-year plan to drive operational improvements and create value with sustainable impact, within a challenging macro environment.&nbsp;
For 2025, Philips expects:&nbsp;
• 1%-3% comparable sales growth, including a mid- to high-single-digit decline in China
&nbsp;• Adjusted EBITA margin increasing 30-80 bps to 11.8%-12.3%&nbsp;
• Free cash flow before payment of the USD 1.1 billion cash-out relating to the US medical monitoring and personal injury settlements will be at the lower end of the range of EUR 1.4 billion to EUR 1.6 billion. Net of this cash-out, free cash flow will be EUR 0.4 billion to EUR 0.6 billion.

Koninklijke Philips For 2025 Expects 1%-3% Comparable Sales Growth, Adjusted EBITA Margin Of 11.8%-12.3%; Sees Free Cash Flow Of EUR 0.4B-EUR 0.6B

Comparable order intake increased 2% in the quarter, with strong performance in the North America and Growth geographies, partly offset by a double-digit decline in demand in China. Group comparable sales increased 1% in the quarter, with solid growth of 5% in the rest of the world, largely offset by a double-digit decline in China, where market conditions are expected to remain uncertain.&nbsp;
Adjusted EBITA increased 60 basis points to 13.5% in Q4, driven by operational improvements and productivity measures. Free cash flow increased to EUR 1.3 billion in the quarter, driven by Respironics insurance proceeds, partly offset by phasing in working capital

Koninklijke Philips Q4 Comparable Order Intake Up 2%, Driven By North America And Growth Markets; Comparable Sales Rise 1%, With 5% Growth Outside China Offset By A Double-Digit Decline

Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported quarterly earnings of €0.51 per share which missed the analyst consensus estimate of €0.57 by 10.53 percent. This is a 27.5 percent increase over earnings of €0.40 per share from the same period last year. The company reported quarterly sales of €5.044 billion which missed the analyst consensus estimate of €5.100 billion by 1.10 percent. This is a 0.47 percent decrease over sales of €5.068 billion the same period last year.

Earnings Misses

Koninklijke Philips Q4 2024 Adj. EPS €0.51 Misses €0.57 Estimate, Sales €5.044B Miss €5.100B Estimate

Press Releases

Philips and Ingeborg Initiatives address maternal health challenges in Arkansas with access to critical resources through the Philips Avent Pregnancy+ app

Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators

Philips convenes the Annual General Meeting of Shareholders 2025

Comments

Koninklijke Philips

空売り

Koninklijke Philips (NYSE:PHG) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル